(Q40280165)

19 September 2017

Diabetes and the risk of prostate cancer: the role of diabetes treatment and complications (English)

1 reference

19 September 2017

1 reference

Velicer CM

1

1 reference

19 September 2017

Dublin S

series ordinal

2

1 reference

19 September 2017

White E

series ordinal

3

1 reference

19 September 2017

language of work or name

1 reference

10 October 2006

1 reference

Prostate Cancer and Prostatic Diseases

19 September 2017

1 reference

19 September 2017

10

1 reference

19 September 2017

1

1 reference

19 September 2017

46-51

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.pcan.4500914

19 September 2017

0 references

cites work

Diabetes mellitus and risk of prostate cancer (United States).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500914

Reduced risk of prostate cancer among patients with diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500914

History of diabetes mellitus and risk of prostate cancer in physicians

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500914

Diabetes mellitus and prostate cancer risk among older men: population-based case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500914

Diabetes mellitus and risk of prostate cancer: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500914

History of diabetes, clinical features of prostate cancer, and prostate cancer recurrence-data from CaPSURE (United States).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500914

Diabetes mellitus and the risk of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500914

IGFs and IGFBPs: role in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500914

Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500914

Interrelationships between plasma testosterone, SHBG, IGF-I, insulin and leptin in prostate cancer cases and controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500914

Nutrition, insulin, insulin-like growth factors and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500914

Insulin-resistant patients with type 2 diabetes mellitus have higher serum leptin levels independently of body fat mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500914

Leptin and prostate: implications for cancer prevention--overview of genetics and molecular interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500914

Close relation of fasting insulin-like growth factor binding protein-1 (IGFBP-1) with glucose tolerance and cardiovascular risk in two populations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500914

Low circulating levels of insulin-like growth factor binding protein-1 (IGFBP-1) are closely associated with the presence of macrovascular disease and hypertension in type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500914

Serum insulin-like growth factor (IGF)-I and IGF-binding protein-1 in elderly people: relationships with cardiovascular risk factors, body composition, size at birth, and childhood growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500914

A polymorphism in the gene for IGF-I: functional properties and risk for type 2 diabetes and myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500914

The role of IGF-I in the development of cardiovascular disease in type 2 diabetes mellitus: is prevention possible?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500914

Effects of ligand activation of peroxisome proliferator-activated receptor gamma in human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500914

Diabetes and Risk of Prostate Cancer in a Prospective Cohort of US Men

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500914

Diabetes Mellitus and the Risk of Prostate Cancer in Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500914

VITamins And Lifestyle Cohort Study: Study Design and Characteristics of Supplement Users

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500914

Prostate cancer risk among men with diabetes mellitus (Spain)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500914

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.PCAN.4500914

1 reference

Dimensions Publication ID

19 September 2017

0 references

1 reference